Botox crow’s feet: why, how and with which toxin?
Crow’s feet are the fan-shaped lines at the outer corner of the eye that show when you smile. In France, several type A botulinum toxins are approved to soften them temporarily; the short-acting toxin is not approved for this area. Here are the muscle involved, onset, duration, risks and questions to ask.
Crow’s feet are one of the eleven areas of our guide to botulinum toxin, area by area. Together with frown lines and the forehead, they are one of the three areas for which type A toxins have an aesthetic indication in France. This page explains how they are treated, with which toxins and with what risks. It does not replace a consultation.
Why are crow’s feet treated?
Crow’s feet are fine lines fanning out from the outer corner of the eye. The labels call them "lateral canthal lines" or "lateral periorbital lines"1,3. They show when you smile, because the orbicularis oculi, a ring of muscle that surrounds the eye and closes it, creases the skin at the corner of the eye.
Botulinum toxin temporarily relaxes the outer part of this muscle. The creasing is less marked when you smile, and the lines deepen less. The labels describe injection at a few points on each side, into the muscle, just under the skin, to limit the spread of the toxin3.
What the toxin does not do: it does not correct under-eye bags or dark circles, or fine lines related to skin quality that remain visible without any movement. Nor should it reach the eyelid: the page on injections near the eyelids explains why this neighbouring area is protected.
When is the toxin used?
The labels concern moderate to severe crow’s feet seen at a full smile, when their severity has an important psychological impact, in adults1,2,3,4. Crow’s feet can be treated alone or at the same time as frown lines or the forehead; the labels describe these combined treatments1.
The labels contraindicate injection in case of allergy to the toxin or to a component of the product, a generalised disorder of the muscles and of the junction between nerve and muscle (myasthenia gravis, Lambert-Eaton syndrome), or an infection at the injection site1,2,3. Treatment is not recommended during pregnancy or breastfeeding1.
Which toxin for crow’s feet?
| Toxin | Status in France |
|---|---|
| Long-acting botulinum toxin (type A) | Approved for aesthetic use in this area (SmPC in force in France) |
| Short-acting botulinum toxin (serotype E) | No aesthetic indication for this area in the SmPCs in force in France: off-label use, to be discussed with your doctor |
Depending on the product: not every type A toxin approved for aesthetic use covers this area.
Several type A toxins are approved for this area in France, but not all of them: some cover only frown lines1,2,3,4. Your doctor chooses the product taking these indications into account, as well as your age, since several of them are indicated only before 652,3,4.
The short-acting botulinum toxin (serotype E) is approved for frown lines only, in the European Union and in Canada: crow’s feet are not part of its marketing authorisation5,6. Using it in this area would be off-label and has not been evaluated in its trials5.
Is it right for me?
Your doctor will look at your lines at rest and when you smile, the quality of your skin, and the position of your eyelids and cheekbones. They will take into account your medical history, in particular dry eyes or eyelid surgery, your treatments and any pregnancy plans.
Age matters: several toxins approved for this area are indicated only in adults under 652,3,4, and data are limited after 65 for another one1.
Questions to ask your doctor: should frown lines or the forehead be treated too? Could my smile change? I have dry eyes: is that a problem? How long should the effect last?
Onset and duration
For the type A toxins approved for crow’s feet, improvement appears in the first few days (within 6 days according to one label), the peak effect is seen around day 30, and the effect lasts up to about 4 months1,3, with a median duration of 4 months according to one label1. For one of the approved toxins, the effect has been shown for 6 months4. Sessions are at least 3 months apart1,3.
To understand these different stages, see the page on how long botulinum toxin takes to work.
What are the risks in this area?
For crow’s feet, the labels describe small bruises at the injection site, eyelid swelling, dry eyes, headaches, and also a drooping eyelid or a temporary weakness of a facial muscle close to the injection points, classed as common in one of them1,2,3. One label asks to avoid injecting too close to the zygomaticus major to prevent the lip from drooping, which would change the smile3. These effects are temporary.
The neighbouring forehead area has its own risks, covered on the page about forehead lines; so does the nose, just inwards, on the page about bunny lines on the nose.
Difficulty swallowing, speaking or breathing requires immediate medical attention1,3. A visual disturbance should also be checked by a doctor promptly. If something unexpected happens, such as dry eyes or a changed smile, the page on the eyes and crow’s feet after an injection helps you recognise it.
Key points
- Crow’s feet are caused by the outer part of the orbicularis oculi muscle1,3.
- Several type A toxins, not all, have this indication in France; the short-acting toxin does not1,4,5.
- Peak effect around day 30, lasting up to about 4 months, sessions at least 3 months apart1,3.
- Risks specific to this area: bruising, eyelid swelling, dry eyes, drooping eyelid, changed smile if the toxin reaches a nearby muscle1,2,3.
Frequently asked questions
Which botulinum toxin is approved for crow’s feet?
In France, several type A toxins carry the "crow’s feet" indication (lateral canthal lines) in their label, but not all of them1,2,3,4. The short-acting botulinum toxin (serotype E) is approved for frown lines only, in the European Union and Canada: crow’s feet are not part of its approval5,6. Your doctor, who knows these indications, chooses the product.
How long does the effect last on crow’s feet?
According to the labels of the type A toxins approved for this area, improvement appears in the first few days, the peak effect is seen around day 30 and the effect lasts up to about 4 months1,3; for one of the toxins, it has been shown for 6 months4. Sessions are at least 3 months apart1,3. The effect is temporary.
Can my smile change after a crow’s feet injection?
It is a described risk, which injection precautions aim to limit. One label asks to avoid injecting too close to the zygomaticus major, the muscle that lifts the corner of the mouth, to prevent the lip from drooping3. If your smile seems different after an injection, talk to the doctor who performed it. Any difficulty eating or speaking should prompt a medical visit.
Sources
- 1.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 68150775) (opens in a new tab) — French public medicines database (BDPM)
- 2.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 66865211) (opens in a new tab) — French public medicines database (BDPM)
- 3.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 61592762) (opens in a new tab) — French public medicines database (BDPM)
- 4.SmPC of a type A botulinum toxin approved for aesthetic use in France (BDPM, CIS 65066375) (opens in a new tab) — French public medicines database (BDPM)
- 5.Summary of product characteristics of the serotype E botulinum toxin approved in the European Union (EPAR annex I) (opens in a new tab) — European Commission (Union Register of medicinal products)
- 6.Canadian product monograph of the serotype E botulinum toxin (authorization date: 2026-06-22) (opens in a new tab) — Health Canada